Britannia Life Sciences Inc.
BLAB
CNSX
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 693.35% | -4.84% | 33.35% | -44.47% | -24.84% |
Total Receivables | -79.96% | -36.12% | 10.61% | 25.57% | -9.38% |
Inventory | -- | -6.38% | 5.87% | 0.00% | 226.62% |
Prepaid Expenses | 27.82% | -34.48% | -19.76% | 169.15% | -3.09% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 323.98% | -23.46% | 16.59% | -9.43% | -13.74% |
|
|||||
Total Current Assets | 323.98% | -23.46% | 16.59% | -9.43% | -13.74% |
Net Property, Plant & Equipment | -76.72% | -12.69% | -1.53% | -6.68% | 15.15% |
Long-term Investments | -- | -6.37% | 5.87% | 0.02% | -0.90% |
Goodwill | -- | -6.37% | 5.87% | 0.02% | -0.90% |
Total Other Intangibles | -- | 2.96% | 21.56% | 19.91% | 35.86% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -47.57% | -8.54% | 6.10% | -3.43% | -5.46% |
|
|||||
Total Accounts Payable | 2.23% | -26.67% | -2.18% | 18.81% | -23.33% |
Total Accrued Expenses | -15.67% | 89.04% | 96.27% | -38.67% | 8.78% |
Short-term Debt | 3.03% | -6.16% | -80.39% | -0.92% | 19.47% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -92.92% | -3.13% | 9.73% | 3.47% | 4.59% |
Total Finance Division Other Current Liabilities | -- | -6.37% | 5.87% | 0.02% | -- |
Total Other Current Liabilities | -- | -6.37% | 5.87% | 0.02% | -- |
Total Current Liabilities | -68.62% | -4.53% | 6.49% | 2.72% | 81.36% |
|
|||||
Total Current Liabilities | -68.62% | -4.53% | 6.49% | 2.72% | 81.36% |
Long-Term Debt | -65.00% | -13.41% | 12.98% | -10.89% | -10.20% |
Short-term Debt | 3.03% | -6.16% | -80.39% | -0.92% | 19.47% |
Capital Leases | -51.55% | -16.13% | -3.73% | -7.67% | 546.33% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -6.11% | 5.53% | 0.00% | -85.67% |
Total Liabilities | -67.45% | -7.28% | 8.10% | -1.64% | 37.43% |
|
|||||
Common Stock & APIC | 0.10% | -6.11% | 1.31% | -1.06% | -1.67% |
Retained Earnings | 31.55% | 5.44% | -8.19% | -2.96% | -47.84% |
Treasury Stock & Other | -1,041.31% | -68.96% | 156.11% | 25.53% | 28.91% |
Total Common Equity | 433.67% | -26.92% | -19.42% | -22.52% | -69.96% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 433.67% | -26.92% | -19.42% | -22.52% | -69.96% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -7.01% | 10.21% | 0.96% | 3.57% |
Total Equity | 8.09% | -11.87% | 1.13% | -7.62% | -45.33% |
|